Ovid Therapeutics Inc. (OVID)
NASDAQ · Healthcare
Ovid Therapeutics Inc. Shareholder Equity 2020–2025
Ovid Therapeutics Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Ovid Therapeutics Inc. shareholder equity as of December 31, 2025: 130.7M, a 91.51% increase year-over-year.
- Ovid Therapeutics Inc. shareholder equity for 2025 were 130.7M, a 91.51% increase from 2024.
- Ovid Therapeutics Inc. shareholder equity for 2024 were 68.2M, a 22.29% decrease from 2023.
- Ovid Therapeutics Inc. shareholder equity for 2023 were 87.8M, a 33.62% decrease from 2022.
- Ovid Therapeutics Inc. shareholder equity for 2022 were 132.3M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Ovid Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $131 |
| 2024 | $68 |
| 2023 | $88 |
| 2022 | $132 |
| 2021 | $180 |
| 2020 | $44 |
Ovid Therapeutics Inc. Shareholder Equity — FAQ
Ovid Therapeutics Inc. (OVID) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see OVID's shareholder equity history?
The chart and table above show Ovid Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.